Characterization of four basic models of indirect pharmacodynamic responses

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 24, Issue 6, 1996, Pages 611-635

  Sharma, Amarnath ^a,b   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Indirect response models; Pharmacodynamics

Indexed keywords

METHYLPREDNISOLONE;

ARTICLE; BLOOD LEVEL; COMPUTER SIMULATION; DOSE TIME EFFECT RELATION; DRUG RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MODEL; PHARMACODYNAMICS; PRIORITY JOURNAL; THEORY;

COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MATHEMATICAL COMPUTING; METHODS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 0030429755     PISSN: 0090466X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02353483     Document Type: Article

References (14)

1. N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm. 21:457-478 (1993).
2. R. Nagashima, R. A. O'Reilly, and G. Levy. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin. Clin. Pharmacol. Ther. 10:22-35 (1969).
3. W. J. Jusko and H. C. Ko. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin. Pharmacol. Ther. 56:406-419 (1994).
4. K. H. Lew, E. A. Ludwig, M. A. Milad, K. Donovan, E. Middleton, Jr., J. J. Ferry, and W. J. Jusko. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 54:402-414 (1993).
5. M. A. Milad, E. A. Ludwig, S. Ane, E. Middleton, and W. J. Jusko. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J. Pharmacokin. Biopharm. 22:469-480 (1995).
6. J. C. Dearden. Partitioning and lipophilicity in quantitative structure-activity relationships. Environ. Health Prosp. 61:203-228 (1985).
7. W. Krzyzanski and W. J. Jusko. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses J. Pharmacokin. Biopharm. accepted (1997).
8. W. Krzyzanski and W. J. Jusko. Integrated functions for four basic models of indirect pharmacodynamic response. Submitted for publication (1996).
9. J. A. Wald, D. E. Salazar, H. Cheng, and W. J. Jusko. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics. J. Pharmacokin. Biopharm. 19:521-536 (1991).
10. H. C. Ko, and W. J. Jusko. Pharmacodynamic modeling of a 5α-reductase inhibitor: Finasteride. Pharmacother. 15:509-511 (1995).
11. Z-X. Xu, M. Lee, R. A. Blum, and W. J. Jusko. Pharmacodynamic modeling of prednisolone effects on natural killer cell trafficking. Pharm. Res. 12:459-463 (1995).
12. W. J. Jusko, H. C. Ko, and W. F. Ebling. Convergence of direct and indirect pharmacodynamic response models. J. Pharmacokin. Biopharm. 23:5-8 (1995).
13. A. Rescigno and G. Segre. Drug and Tracer Kinetics. Chapter 4, Blaisdell Publishing Co., New York, 1966.
14. L. Z. Benet. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. J. Pharm. Sci. 61:536-541 (1972).